A5040053473- Acute Lymphoblastic Leukemia research
- Viral-associated cancers and disorders
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Acute Myeloid Leukemia Research
- Reproductive Biology and Fertility
- Childhood Cancer Survivors' Quality of Life
- Ovarian function and disorders
- Economic and Financial Impacts of Cancer
- Reproductive Health and Technologies
- CNS Lymphoma Diagnosis and Treatment
- Family Support in Illness
- Polyomavirus and related diseases
- Neutropenia and Cancer Infections
- Cancer survivorship and care
- Multiple Myeloma Research and Treatments
- T-cell and Retrovirus Studies
- BRCA gene mutations in cancer
- Parvovirus B19 Infection Studies
- Renal and related cancers
- Hematopoietic Stem Cell Transplantation
- Immune Cell Function and Interaction
- Cutaneous lymphoproliferative disorders research
- Autoimmune and Inflammatory Disorders Research
- Hemoglobinopathies and Related Disorders
University of California, San Diego
2021-2024
Northwestern University
2010-2022
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
2021
Indo-American Center
2021
Takeda (United States)
2020
Loyola University Chicago
2017
Rosalind Franklin University of Medicine and Science
2013
Rosalind Franklin Institute
2011
Franklin University
2011
This article explores how 70 younger women diagnosed with breast cancer draw on social support resources. The authors found that most respondents' core networks were their families, and came in several forms including emotional, tangible, informational. However, the also many respondents relied a distinct form of support, experiential which has not been identified current research. Experiential is defined as relationship someone who gone through similar illness can help provide firsthand...
IN JUNE 2006, THE AMERICAN SOCIETY OF CLINICAL ONcology published a series of recommendations on fertility preservation for patients with cancer, concluding that “To preserve the full range options, approaches should be considered as early possible during treatment planning.” These guidelines reflect greater attention has been given in recent years to complications can occur result cancer (eg, chemotherapies and radiation). Other professional collaborative societies, including Oncofertility...
Treatment strategies for post-transplant lymphoproliferative disorders (PTLD) consist of response-adapted risk-stratified methods using immunosuppression reduction, immunotherapy, and chemotherapy. We investigated the efficacy Brentuximab vedotin given concurrently with Rituximab (BV + R) once weekly four weeks, followed by optional consolidation, up to one year maintenance. Among 20 assessable patients, BV R therapy resulted in an overall response rate 75% (95% CI 51 91, p = 0.044) 60%...
Background: Due to its ability vivo T-cell deplete, antithymocyte globulin (ATG) has been administered patients undergoing allogeneic transplantation (Allo-SCT) considered high risk for graft rejection. This includes those receiving HLA-mismatched allografts, unrelated and who have not received intensive or highly immunosuppressive chemotherapy during the few months before transplantation. While ATG may decrease rejection vs host disease (GVHD), these benefits might be offset by an increased...